Physician profile
Meghan Richardson
NPI 1881012326
$20,664.47
in general payments reported to CMS, 2019-2025
14 companies · $2,124 in 2025
The $2,124 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $6,506 · 2021: $4,947 · 2022: $2,797 · 2023: $1,311 · 2024: $2,454 · 2025: $2,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,517 · Food and Beverage: $2,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,516.62 |
| Food and Beverage | $2,372.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,577.60 | 2020-2025 | The Pink Hip Kit - Smith & Nephew Table, Q-Fix, Bone Anchors With Arthroscopic Delivery System |
| Fortis Surgical, LLC | $6,715.41 | 2020-2025 | |
| Arthrex, INC. | $3,365.76 | 2021-2025 | |
| Stryker Corporation | $1,847.32 | 2020-2025 | Salvation, Nanotack Flex, Cobra |
| Southtech Orthopedics | $420.00 | 2019 | |
| Impactortho, INC. | $141.08 | 2023 | |
| Biocomposites INC | $130.14 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $121.72 | 2025 | Exparel |
| Onkos Surgical, INC. | $105.65 | 2019 | |
| Ferring Pharmaceuticals INC. | $86.73 | 2023-2024 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $48.42 | 2023 | Tricera Handpiece |
| Gotham Surgical Solutions & Devices, INC. | $46.47 | 2022 | |
| Aesculap Biologics, LLC | $35.71 | 2020 | |
| Depuy Synthes Sales INC. | $22.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.